Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DOVONEX 50 MCG

CALCIPOTRIOL : 50 MCG · DIN 01976133 · LEO PHARMA INC

Health Canada status: MARKETED

What is DOVONEX?

DOVONEX 50 MCG contains CALCIPOTRIOL : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 01976133, held by LEO PHARMA INC, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1992. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What else is DOVONEX called?

The same molecule, CALCIPOTRIOL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
DAIVONEXLatinBrazil, Morocco
EnstilarLatinAustralia, Czechia
DaivobetLatinAustralia
KlarvantaLatinAustralia
TALIZONLatinCzechia
WYNZORALatinCzechia
Xamiol GelLatinSouth Africa

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN01976133
Brand nameDOVONEX
Generic / active ingredientCALCIPOTRIOL : 50 MCG
ManufacturerLEO PHARMA INC
Strength50 MCG
Dosage formOINTMENT
Route of administrationTOPICAL
SchedulePrescription
ATC codeD05AX02 CALCIPOTRIOL
AHFS class84:92.00
BiosimilarNo
Health Canada statusMARKETED
Status date31-Dec-1992
Original market date1992-12-31 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)01976133
DIN (unpadded, as printed on some documents)1976133
Brand nameDOVONEX
Active ingredient / INNCALCIPOTRIOL : 50 MCG
ATC codeD05AX02
ATC anatomical main groupD — Dermatologicals
ATC therapeutic subgroupD05
AHFS class84:92.00
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderLEO PHARMA INC

Health Canada approved product monograph (PDF)

Which pack is which?

Strength on the label50 MCG
Dosage formOINTMENT
RouteTOPICAL

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

What can be used instead?

Other Canadian products sharing ATC code D05AX02 CALCIPOTRIOL. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
DOVONEX - CRM 50MCG/GM50 MCGCREAMLEO PHARMA INCCANCELLED POST MARKETDIN 02150956
DOVONEX SOLUTION - TOP 50MCG/ML50 MCGSOLUTIONLEO PHARMA INCCANCELLED POST MARKETDIN 02194341

Who else supplies CALCIPOTRIOL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. CALCIPOTRIOL appears in 32 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does CALCIPOTRIOL cost around the world?

CALCIPOTRIOL is listed on 10 national price registers Nexara tracks, across 44 pack listings published on 9 different price bases. What each country publishes is set out below.

MarketWhat that country publishesBrands listedPack listingsAs of
Australiaex-manufacturer61208 Sep 2026
SpainPVP con IVA (public price)6605 Sep 2026
Luxembourgreimbursement6605 Sep 2026
AustriaKVP (Kassenverkaufspreis)3403 Sep 2026
Czechiamax producer price (ex-factory)3303 Sep 2026
Greeceproducer price (ex-factory)3303 Sep 2026
Hungaryproducer price (ex-factory)3303 Sep 2026
MoroccoPPV (public price)1305 Sep 2026
South Africasingle exit price2301 Sep 2026
Brazilpreco fabrica (ex-factory ceiling)1102 Sep 2026

Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.

Ask Nexara for a landed Canadian price

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for DOVONEX

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 01976133. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.